Agenus (AGEN) Cash from Operations (2010 - 2026)
Agenus' (AGEN) quarterly Cash from Operations came in at 35950000.0 in Q1 2026, down 40.33% year-on-year from 60249057.96 in Q1 2025, and down 116.33% quarter-over-quarter from 16618000.0 in Q4 2025.
Agenus (AGEN) Cash from Operations (2010 - 2026) Analysis & Trends
Agenus' Cash from Operations history runs 17 years deep, the most recent figure standing at 35950000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 40.33% year-over-year to 35950000.0 in Q1 2026; TTM through Mar 2026 was 87527000.0, a 39.94% increase from a year earlier, with the FY2025 full-year figure at 77195000.0, up 51.24% from the prior year.
- Cash from Operations retreated to 35950000.0 in Q1 2026 per AGEN's latest filing, from 16618000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 14737000.0 in Q3 2025 and bottomed at 65231000.0 in Q3 2023.
- The 5-year median for Cash from Operations is 38191000.0 (2024), against an average of 39472647.06.
- Across the five-year window, Cash from Operations sank 124.5% in 2022 and soared 72.35% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 47338000.0 in 2022, then increased by 14.65% to 40402000.0 in 2023, then advanced by 29.08% to 28652000.0 in 2024, then jumped by 42.0% to 16618000.0 in 2025, then tumbled by 116.33% to 35950000.0 in 2026.
- Per Business Quant, the three latest AGEN Cash from Operations figures stand at 35950000.0 (Q1 2026), 16618000.0 (Q4 2025), and 14737000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -35.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.95 Mn |
| Mar 31, 2026 | -35.95 Mn |
| Dec 31, 2025 | -16.62 Mn |
| Dec 31, 2025 | -16.62 Mn |
| Sep 30, 2025 | -14.74 Mn |
| Sep 30, 2025 | -14.74 Mn |
| Jun 30, 2025 | -20.22 Mn |
| Jun 30, 2025 | -20.22 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Dec 31, 2024 | -28.65 Mn |
| Dec 31, 2024 | -28.65 Mn |
| Sep 30, 2024 | -53.29 Mn |
| Sep 30, 2024 | -53.29 Mn |
| Jun 30, 2024 | -38.18 Mn |
| Jun 30, 2024 | -38.18 Mn |
| Mar 31, 2024 | -38.19 Mn |
| Mar 31, 2024 | -38.19 Mn |
| Dec 31, 2023 | -40.40 Mn |
| Dec 31, 2023 | -40.40 Mn |